Amide prodrug of gemcitabine, compositions and use thereof
US7691827B2 · kind B2 · utility
3Cited by
10References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2005 |
| Grant date | Apr 6, 2010 |
| Priority date | — |
| Expiry date | Jan 13, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the gemcitabine prodrug 1-(2,2-difluoro-2-deoxy-β-D -ribofuranosyl)-4-(2-propyl-1-oxopentyl)aminopyrimidin-2-one useful as an oral drug for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.